1-2 of 2
Guillaume Morel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Stem Cell Transplant in 2 nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience

Aude Collignon, Benjamin Bouchacourt, Patrick Sfumato, Gabriel Brisou, Jean Marc Schiano de Collela, Luca Inchiappa, Boris Calmels, Claude Lemarié, Tibaulth Reichert, Samia Harbi, Raynier Devillier, Anne Calleja, Thomas Pagliardini, Guillaume Morel, Angela Granata, Norbert Vey, Reda Bouabdallah, Didier Blaise, Christian Chabannon, Robin Noel, Catalina Montes De Oca
Journal: Blood
Blood (2022) 140 (Supplement 1): 7712–7713.
https://doi.org/10.1182/blood-2022-158171
Published: 2022
Journal Articles

CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapies

CME Clinical Trials & Observations
Marie Le Cann, Françoise Bouhour, Karine Viala, Laurence Simon, Céline Tard, Cédric Rossi, Guillaume Morel, Emmeline Lagrange, Laurent Magy, Alain Créange, Maud Michaud, Jérôme Franques, Andoni Echaniz-Laguna, Jean-Christophe Antoine, Marine Baron, Bertrand Arnulf, Angela Puma, Emilien Delmont, Thierry Maisonobe, Véronique Leblond, Damien Roos-Weil
Journal: Blood
Blood (2020) 136 (21): 2428–2436.
https://doi.org/10.1182/blood.2020007092
Published: 2020
Includes: Supplemental data